4.8 Article

Precise and combinatorial PEGylation generates a low-immunogenic and stable form of human growth hormone

期刊

JOURNAL OF CONTROLLED RELEASE
卷 249, 期 -, 页码 84-93

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2017.01.029

关键词

Expanded genetic code; Copper-free click chemistry; Multisite specific PEGylation; Recombinant human growth hormone

资金

  1. National Natural Science Foundation of China [81530090, 81673342, 21572015]
  2. National Key Research and Development Program of China [2016YFA0501500]

向作者/读者索取更多资源

In this study, we aimed to develop a safe and stable form of human growth hormone (hGH) and to refine PEGylation methods for therapeutic proteins via genetic code expansion. Through this precise approach, a series of polyethylene glycol (PEG) moieties and sites were combined in various ways. Additionally, the effects of combinatorial PEGylation on the biological, pharmacological, and immunogenic properties of hGH in vitro and vivo were analyzed. Our results showed that combinatorial PEGylation at Y35, G131, and K145 significantly reduced immunogenicity and improved pharmacokinetic (PK) profiles compared with mono-PEGylation, while retaining biological activity. Upon re-examination of the pharmacodynamics in hypophysectomized rats, multi-PEGylated hGH was found to be much more stable than mono-PEGylated hGH. Thus, this method for combinatorial, precise PEGylation may facilitate the development of next-generation, long-acting hGH with low immunogenicity. (C) 2017 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Synthesis of a Hexavalent Betulinic Acid Derivative as a Hemagglutinin-Targeted Influenza Virus Entry Inhibitor

Yingying Chen, Xinchen Wang, Yinbiao Zhu, Longlong Si, Bo Zhang, Yongmin Zhang, Lihe Zhang, Demin Zhou, Sulong Xiao

MOLECULAR PHARMACEUTICS (2020)

Article Rheumatology

In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells

Bo Zhang, Yan Wang, Yeshuang Yuan, Jiaqi Sun, Lulu Liu, Dan Huang, Jin Hu, Min Wang, Shengjie Li, Wei Song, Hua Chen, Demin Zhou, Xuan Zhang

Summary: Autoreactive B cells play a crucial role in the pathogenesis of rheumatoid arthritis (RA), and targeting these cells using FITC-labelled antigenic peptide epitopes with universal CAR-T cells shows promise for precise and customized treatment of RA and potentially other systemic autoimmune diseases.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Oncology

Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model

Ling Wu, Joanna Brzostek, Shvetha Sankaran, Qianru Wei, Jiawei Yap, Triscilla Y. Y. Tan, Junyun Lai, Paul A. MacAry, Nicholas R. J. Gascoigne

Summary: Chimeric antigen receptors (CARs) redirect T cells effectively in combating cancers and have achieved great success in clinical practice. However, the mechanisms underlying CAR signaling and function are not fully understood. Research findings suggest that CAR and TCR exhibit distinct signaling characteristics, providing new insights for clinical behavior of CAR-T therapy and technology optimization.

CANCERS (2021)

Meeting Abstract Hematology

METTL3 Dysregulates RNA Splicing by Translational Control of Splicing Factors via m 6A Modification in CLL

Yiming Wu, Meiling Jin, Mike Fernandez, Kevyn Hart, Aijun Liao, Stacey M. Fernandes, Tinisha McDonald, Lucy Ghoda, Daniel Roeth, Markus Kalkum, Raju Pillai, Jianjun Chen, Jennifer R. Brown, Alexey V. Danilov, Steven T. Rosen, Tanya Siddiqi, Lili Wang

Article Biochemistry & Molecular Biology

Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates

Xinyu Ling, Liying Chang, Heqi Chen, Xiaoqin Gao, Jianhang Yin, Yi Zuo, Yujia Huang, Bo Zhang, Jiazhi Hu, Tao Liu

Summary: Researchers have improved the genome editing efficiency of the Cas12a system by covalently linking CRISPR RNA and Cas12a, achieving high-efficiency gene editing and providing a new approach for engineering other low-efficiency Cas family members.

MOLECULAR CELL (2021)

Article Engineering, Biomedical

Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells

Bo Zhang, Jiaqi Sun, Yan Wang, Dezhong Ji, Yeshuang Yuan, Shengjie Li, Yeting Sun, Yingqin Hou, Pengchong Li, Lidan Zhao, Fei Yu, Wenxiao Ma, Boyang Cheng, Ling Wu, Jin Hu, Min Wang, Wei Song, Xiaogang Li, Hao Li, Yunyun Fei, Hua Chen, Lihe Zhang, George C. Tsokos, Demin Zhou, Xuan Zhang

Summary: Orthogonal conjugation of the cytokine interleukin-2 to poly(ethylene glycol) moieties at defined protein sites improves its pharmacokinetics and half-life as well as its therapeutic performance in mouse models of autoimmune diseases.

NATURE BIOMEDICAL ENGINEERING (2021)

Article Endocrinology & Metabolism

Integrative metabolomic profiling reveals aberrations in myometrium associated with adenomyosis: a pilot study

Wei Song, Zhibo Zhang, Ying Jiang, Yang Cao, Bo Zhang, Yujie Wang, Honghui Shi, Lan Zhu

Summary: This study is the first to describe the metabolic features of the adenomyosis uterus, identifying 106 differentially expressed metabolites related to inflammation, oxidative stress, cell proliferation and apoptosis, and energy metabolism.

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2022)

Review Biochemistry & Molecular Biology

Therapeutic potential of interleukin-2 in autoimmune diseases

Yeshuang Yuan, Antonios G. A. Kolios, Yudong Liu, Bo Zhang, Hao Li, George C. Tsokos, Xuan Zhang

Summary: Autoimmune diseases can be treated by restoring immune balance, and low-dose interleukin-2 (IL-2) has immunoregulatory effects on regulatory T cells (T-reg cells). Recent advances have explored the therapeutic potential of IL-2 or IL-2-derived molecules in the treatment of autoimmune diseases.

TRENDS IN MOLECULAR MEDICINE (2022)

Review Biology

CARs: a new approach for the treatment of autoimmune diseases

Yeting Sun, Yeshuang Yuan, Bo Zhang, Xuan Zhang

Summary: The development of CAR-based therapeutic interventions has revolutionized cancer treatment and has also shown potential in treating autoimmune diseases. CAR-T cells can effectively deplete pathological immune cells, while CAR-Tregs have the ability to restore immune tolerance. The optimization of CAR structure and function has been influenced by previous experience in the field of cancer. This review discusses the potential application of CAR-T cells and CAR-Tregs in treating autoimmune diseases, as well as the strategies of gene editing and synthetic biological tools that have improved CAR-based therapies.

SCIENCE CHINA-LIFE SCIENCES (2023)

Article Biochemistry & Molecular Biology

Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity

Bo Zhang, Jiaqi Sun, Yeshuang Yuan, Dezhong Ji, Yeting Sun, Yudong Liu, Shengjie Li, Xingxing Zhu, Xunyao Wu, Jin Hu, Qiu Xie, Ling Wu, Lulu Liu, Boyang Cheng, Yuanjie Zhang, Lingjuan Jiang, Lidan Zhao, Fei Yu, Wei Song, Min Wang, Yue Xu, Shiliang Ma, Yunyun Fei, Lihe Zhang, Demin Zhou, Xuan Zhang

Summary: In this study, a strategy was developed to selectively activate regulatory T cells (Tregs) using IL-2 variants that covalently bind to IL-2R alpha. The IL-2 variants, containing a bioreactive artificial amino acid, fluorosulfate-L-tyrosine (FSY), showed enhanced therapeutic efficacy in murine models of lupus and graft-versus-host disease (GvHD). Furthermore, N-terminal PEGylation of the IL-2 variants improved their circulatory retention and sustained effects. This proximity-enabled covalent binding strategy has the potential to accelerate the development of immunomodulatory therapies.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Article Medicine, Research & Experimental

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma

Shuhua Yi, Yuting Yan, Meiling Jin, Supriyo Bhattacharya, Yi Wang, Yiming Wu, Lu Yang, Eva Gine, Guillem Clot, Lu Chen, Ying Yu, Dehui Zou, Jun Wang, An T. Phan, Rui Cui, Fei Li, Qi Sun, Qiongli Zhai, Tingyu Wang, Zhen Yu, Lanting Liu, Wei Liu, Rui Lyv, Weiwei Sui, Wenyang Huang, Wenjie Xiong, Huijun Wang, Chengwen Li, Zhijian Xiao, Mu Hao, Jianxiang Wang, Tao Cheng, Silvia Bea, Alex F. Herrera, Alexey Danilov, Elias Campo, Vu N. Ngo, Lugui Qiu, Lili Wang

Summary: This study identified four distinct genetic subsets of mantle cell lymphoma (MCL) and demonstrated the impact of clonal evolution on clinical outcomes. These findings provide valuable insights into the heterogeneity of MCL and its genetic determinants.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Biochemistry & Molecular Biology

Enhancement of bioactivity, thermal stability and tumor retention by self-fused concatenation of green fluorescent protein

Jin Hu, Jianquan Shi, Yeshuang Yuan, Bo Zhang, Shengjie Li, Haitao Dong

Summary: A simple and universal protein modification approach (SEC) was discovered to enhance the thermal stability and tumor retention of proteins. Concatenating self-fused proteins can significantly improve the bioactivity and stability of proteins.

BIOCHEMISTRY AND BIOPHYSICS REPORTS (2021)

Article Biochemistry & Molecular Biology

Photoswitchable CAR-T Cell Function In Vitro and In Vivo via a Cleavable Mediator

Bo Zhang, Yan Wang, Shenlong Huang, Jiaqi Sun, Min Wang, Wenxiao Ma, Yanbo You, Ling Wu, Jin Hu, Wei Song, Xudong Liu, Shengjie Li, Hua Chen, Guisheng Zhang, Lihe Zhang, Demin Zhou, Lingjun Li, Xuan Zhang

Summary: This study demonstrates a photoswitchable approach to regulate CAR-T cells, allowing rapid termination of cytotoxicity without compromising tumor therapy.

CELL CHEMICAL BIOLOGY (2021)

Meeting Abstract Hematology

Integrative Transcriptome and Quantitative Proteome Analyses Identify METTL3 As a Key Regulator for Aberrant RNA Processing in Chronic Lymphocytic Leukemia

Yiming Wu, Meiling Jin, Kevyn Hart, Aijun Liao, Stacey M. Fernandes, Tinisha McDonald, Lucy Brown, Daniel Roeth, Markus Kalkum, Raju Pillai, Jianjun Chen, Jennifer R. Brown, Steven T. Rosen, Tanya Siddiqi, Lili Wang

Review Chemistry, Multidisciplinary

Polymer mechanochemistry in drug delivery: From controlled release to precise activation

Zhiyuan Shi, Yong Hu, Xin Li

Summary: Controlled drug delivery systems that can respond to mechanical force offer a unique solution for on-demand drug activation and release. Among various mechanical stimuli, ultrasound (US) has advantages in achieving spatiotemporally controlled drug release. Traditional US-triggered drug release relies on heat-induced phase transitions or chemical transformations, while the cutting-edge approach of Sonopharmacology leverages polymer mechanochemistry. The remaining challenges and potential future directions in this field are also discussed.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis

Lijie Zheng, Yuanzheng Chen, Xun Gu, Yingying Li, Hanqing Zhao, Wenjun Shao, Tao Ma, Chuanbin Wu, Qingqing Wang

Summary: In this study, a novel dosage form consisting of dissolving microneedles and an adhesive transdermal patch was developed for the treatment of rheumatoid arthritis. In vitro and in vivo experiments demonstrated that the combination of drugs delivered by this dosage form effectively reduced joint inflammation and damage.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mucoadhesive chitosan microcapsules for controlled gastrointestinal delivery and oral bioavailability enhancement of low molecular weight peptides

Kyungjik Yang, Hwa Seung Han, Seung Hwan An, Kyung Hoon Park, Keonwook Nam, Shinha Hwang, Yuyeon Lee, Sung Yeon Cho, Taehyung Kim, Deokyeong Choe, Sang Won Kim, Wonkyu Yu, Hyunah Lee, Jiyong Park, Sangguan You, Dong- Gyu Jo, Ki Young Choi, Young Hoon Roh, Jae Hyung Park

Summary: This study developed CP-loaded CS microcapsules to enhance the oral bioavailability of CP through controlled gastrointestinal delivery. The optimized microcapsules exhibited desirable physicochemical properties, showed anti-photoaging effects via antioxidant activity, and achieved controlled release in the gastrointestinal tract. This research provides a simple and economical approach for enhancing the oral bioavailability of CP for customized bioactive compound administration.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema

Huiyang Li, Shuo Liu, Wenjin Dai, Bingmei Yao, Yong Zhou, Sujia Si, Hairong Yu, Riguang Zhao, Fang Jin, Liqun Jiang

Summary: Changes in bodily fluid pressures are crucial in diseases like high-altitude pulmonary edema (HAPE). Researchers have developed hydrostatic pressure-sensitive multivesicular liposomes (PSMVLs) that can release drugs in response to pressure changes, with potential applications in HAPE treatment. Animal experiments showed that this system provides better protection for lung tissues and respiratory function, reducing the occurrence of pulmonary edema.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Biofunctional coacervate-based artificial protocells with membrane-like and cytoplasm-like structures for the treatment of persistent hyperuricemia

Qian Hu, Hongbing Lan, Yinmei Tian, Xiaonan Li, Mengmeng Wang, Jiao Zhang, Yulin Yu, Wei Chen, Li Kong, Yuanyuan Guo, Zhiping Zhang

Summary: Coacervate droplets formed through liquid-liquid phase separation have potential as delivery vesicles for therapeutics. However, their lack of physiological stability and membranes are challenges. In this study, polylysine-polynucleotide complex coacervate droplets with favorable stability were formulated to concentrate molecules and nanoparticles. Phospholipid membranes were further coated on the droplets to create coacervate-based artificial protocells (ArtPC) with membrane-like structures. These biofunctional ArtPC effectively reduced blood uric acid levels and prevented renal injuries.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer

Xiaowei Wang, Hongwei Lu, Fang Luo, Dan Wang, Apeng Wang, Xuelei Wang, Wenkai Feng, Xiaobo Wang, Jiayi Su, Mingliang Liu, Guimin Xia

Summary: Four novel lipid-like GEM diesters were synthesized and encapsulated into liposomes to improve the antitumor efficacy of Gemcitabine. The liposomes loaded with dimyristoyl GEM (LipodmGEM) showed enhanced cellular uptake, improved inhibition of cell migration, and a greatly extended half-life compared to free Gemcitabine. LipodmGEM successfully enriched the drug in the tumor and exhibited excellent anticancer efficacy in vivo with negligible systemic toxicity.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment

Pengyu Li, Jieyi Pan, Yating Dong, Yingying Sun, Yalong Wang, Kang Liao, Yili Chen, Xin Deng, Shihui Yu, Haiyan Hu

Summary: Chronic pulmonary infection caused by Pseudomonas aeruginosa is a serious public health problem with high mortality rates. In this study, infection-microenvironment responsive nanoparticles were developed to eradicate biofilms and inhibit virulence. These nanoparticles showed promising results in treating chronic pulmonary infections.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death

Yajing Sun, Ze Lu, John A. Taylor, Jessie L. S. Au

Summary: A recent development in cancer chemotherapy is the use of cytotoxics to induce tumor-specific immune response through immunogenic cell death (ICD). This study describes a method that utilizes immunostaining and machine-learning to identify cells with ecto-CRT in intact 3-dimensional tissues. The method was successfully applied to study drug-induced ICD in human bladder cancer.

JOURNAL OF CONTROLLED RELEASE (2024)

Review Chemistry, Multidisciplinary

Strategies for gaseous neuromodulator release in chemical neuroscience: Experimental approaches and translational validation

Rafat Ali, Shantanu Sen, Rohil Hameed, Aamir Nazir, Sandeep Verma

Summary: This review provides a focused overview of emerging strategies for delivering gasotransmitters in a controlled and sustained manner to reestablish neurophysiological homeostasis.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Multifunctional hydrogel for synergistic reoxygenation and chemo/ photothermal therapy in metastatic breast cancer recurrence and wound infection

Jing Chen, Xinyi Zhang, Jinshen Zhang, Zhaoxia Wang, Guilan Zhu, Ming Geng, Jinmiao Zhu, Yajun Chen, Wei Wang, Youcui Xu

Summary: In this study, a multifunctional responsive hydrogel system was developed for synergistic reoxygenation and chemo/photothermal therapy. The hydrogel system showed both therapeutic effects against metastatic breast cancer and wound infection, making it a promising strategy for treating and preventing tumor recurrence and associated wound infection.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mitochondria-targeted SkQ1 nanoparticles for dry eye disease: Inhibiting NLRP3 inflammasome activation by preventing mitochondrial DNA oxidation

Baoshan Huang, Na Zhang, Xinying Qiu, Rui Zeng, Shuimiao Wang, Mengxia Hua, Qing Li, Kaihui Nan, Sen Lin

Summary: This study revealed that robust ROS can oxidize mitochondrial DNA (ox-mtDNA) and cause its release into the cytosol, resulting in the activation of NLRP3 inflammasome. By using the mitochondria-targeted antioxidant SkQ1 and a novel mitochondria-targeted nanoparticle (SkQ1 NP), it was found that mitochondrial ROS scavenging could in situ inhibit DED-induced mtDNA oxidation and suppress NLRP3-mediated inflammation.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction

Wenqi Liu, Cheng Hu, Linyu Long, Shuyi He, Wen Zhang, Zhicun Wang, Li Yang, Yunbing Wang

Summary: Myocardial infarction is the leading cause of cardiovascular mortality, and current treatment methods have limitations. This study developed a smart carrier that can release different therapeutic substances for different pathological processes, effectively improving cardiac function, promoting cardiac repair, and preventing ventricular remodeling.

JOURNAL OF CONTROLLED RELEASE (2024)